The DOI matches its Crossref record; 181 of the 190 references it cites were found in a registry or an index.
Wnt signaling and cancer
Open accessAbstract
The regulation of cell growth and survival can be subverted by a variety of genetic defects that alter transcriptional programs normally responsible for controlling cell number. High throughput analysis of these gene expression patterns should ultimately lead to the identification of minimal expression profiles that will serve as common denominators in assigning a cancer to a given category. In the course of defining the common denominators, though, we should not be too surprised to find that cancers within a single category may nevertheless exhibit seemingly disparate genetic defects. The wnt pathway has already provided an outstanding example of this. We now know of three regulatory genes in this pathway that are mutated in primary human cancers and several others that promote experimental cancers in rodents (Fig. 1). In all of these cases the common denominator is the activation of gene transcription by -catenin. The resulting gene expression profile should provide us with a signature common to those cancers carrying defects in the wnt pathway. In this review, the wnt pathway will be covered from the perspective of cancer, with emphasis placed on molecular defects known to promote neoplastic transformation in humans and in animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Constitutive activation of this pathway is also implicated in cancer development in several other organs (140).”
From Adrenal incidentaloma (2020) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Kořínek, V., Barker, N., Clevers, H. C., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 4,000
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Identification and characterization of the familial adenomatous polyposis coli gene
Groden, J. L., Thliveris, A. T., Samowitz, W. S., Carlson, M. L., Gelbert, L. M., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L. N., Robertson, M. A., et al. (1991) · Cell · doi:10.1016/0092-8674(81)90021-0 · Cited by 2,794
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,331
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,030
Nusse, R., & VARMUS, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,864
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Flagged first, then by citations
9 of the 190 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1210/jc.85.1.286 · DOI
Cited by
Sorted by citations
Items 101–200 of 1,005
Zechner, D., Fujita, Y., Hülsken, J., Müller, T. H., Walther, I., Taketo, M. M., Crenshaw, E. B., Birchmeier, W., & Birchmeier, C. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00123-4 · Cited by 484
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W.-M. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 499
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Autoregulation of E-cadherin expression by cadherin–cadherin interactions
Conacci‐Sorrell, M., Simcha, I., Ben-Yedidia, T., Blechman, J., Savagner, P., & Ben‐Ze'ev, A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200308162 · Cited by 474
Nuclear transport and cancer: from mechanism to intervention
Kau, T. R., Way, J. C., & Silver, P. A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1274 · Cited by 471
Ryo, A., Nakamura, M., Wulf, G. M., Liou, Y.-C., & Lu, K. P. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-793 · Cited by 470
The cadherin-catenin adhesion system in signaling and cancer
Conacci‐Sorrell, M., Zhurinsky, J., & Ben‐Ze'ev, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215429 · Cited by 464
β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
Hovanes, K., Li, T. W. H., Munguia, J. E., Truong, T., Milovanović, T., Marsh, J., Holcombe, R. F., & Waterman, M. L. (2001) · Nature Genetics · doi:10.1038/ng0501-53 · Cited by 464
Lipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457
β-catenin is critical for dendritic morphogenesis
Yu, X., & Malenka, R. C. (2003) · Nature Neuroscience · doi:10.1038/nn1132 · Cited by 459
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Ly, P. T. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64516 · Cited by 442
“Many of the Wnt signal transduction components such as the APC gene or β-catenin gene carry mutations that render the protein nondegradable (94).”
Oct-3/4 is a dose-dependent oncogenic fate determinant
Gidekel, S., Pizov, G., Bergman, Y., & Pikarsky, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00270-8 · Cited by 439
The establishment of spemann's organizer and patterning of the vertebrate embryo
De Robertis, E. M., Larraín, J., Oelgeschläger, M., & Wessely, O. (2000) · Nature Reviews Genetics · doi:10.1038/35042039 · Cited by 429
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Moon, S.-H., Huang, C., Houlihan, S. L., Regunath, K., Freed-Pastor, W. A., Morris, J. P., Tschaharganeh, D. F., Kastenhuber, E. R., Barsotti, A. M., Culp‐Hill, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.011 · Cited by 447
The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization
Schwarz, T., Fiedler, M., Shibata, N., Butler, P. J. G., Kikuchi, A., Higuchi, Y., & Bienz, M. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1247 · Cited by 429
Hino, S., Tanji, C., Nakayama, K. I., & Kikuchi, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.9063-9072.2005 · Cited by 428
Epigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 439
E‐Cadherin/β‐Catenin Complex and the Epithelial Barrier
Tian, X., Liu, Z.-L., Niu, B., Zhang, J., Tan, T. K., Lee, S. R., Zhao, Y., Harris, D. C. H., & Zheng, G. (2011) · BioMed Research International · doi:10.1155/2011/567305 · Cited by 425
Wnt/β-catenin signaling: new (and old) players and new insights
Huang, H., & He, X. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.009 · Cited by 427
Wnt signaling controls the fate of mesenchymal stem cells
Ling, L., Nurcombe, V., & Cool, S. M. (2008) · Gene · doi:10.1016/j.gene.2008.12.008 · Cited by 417
Molecular Link Mechanisms between Inflammation and Cancer
Costa, D. B. V., & de Carvalho, J. E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083707 · Cited by 426
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
Cadoret, A., Ovejero, C., Terris, B., Souil, E., Lévy, L., Lamers, W. H., Kitajewski, J., Kahn, A., & Perret, C. (2002) · Oncogene · doi:10.1038/sj.onc.1206118 · Cited by 412
Glycogen Synthase Kinase-3: Properties, Functions, and Regulation
Ali, A. H., Hoeflich, K. P., & Woodgett, J. R. (2001) · Chemical Reviews · doi:10.1021/cr000110o · Cited by 413
Lampugnani, M. G., Zanetti, A., Corada, M., Takahashi, T., Balconi, G., Breviario, F., Orsenigo, F., Cattelino, A., Kemler, R., Daniel, T. O., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209019 · Cited by 410
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Crystal Structure of a β-Catenin/Tcf Complex
Graham, T. A., Weaver, C. I., Mao, F., Kimelman, D., & Xu, W. (2000) · Cell · doi:10.1016/s0092-8674(00)00192-6 · Cited by 414
Alternative Wnt Signaling Is Initiated by Distinct Receptors
van Amerongen, R., Mikels, A. J., & Nusse, R. (2008) · Science Signaling · doi:10.1126/scisignal.135re9 · Cited by 408
Morfini, G. A., Szebenyi, G., Elluru, R. G., Ratner, N., & Brady, S. T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.281 · Cited by 406
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 400
Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation
Wu, S., Morin, P. J., Maouyo, D., & Sears, C. L. (2003) · Gastroenterology · doi:10.1053/gast.2003.50047 · Cited by 396
WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription
Chen, S., Guttridge, D. C., You, Z., Zhang, Z., Fribley, A. M., Mayo, M. W., Kitajewski, J., & Wang, C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.1.87 · Cited by 397
Lu, D., Choi, M. Y., Yu, J., Castro, J. E., Kipps, T. J., & Carson, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110431108 · Cited by 395
Update on Wnt signaling in bone cell biology and bone disease
Monroe, D. G., McGee‐Lawrence, M. E., Oursler, M. J., & Westendorf, J. J. (2011) · Gene · doi:10.1016/j.gene.2011.10.044 · Cited by 400
Dysregulated molecular networks in head and neck carcinogenesis
Molinolo, A., Amornphimoltham, P., SQUARIZE, C. H., CASTILHO, R. M., Patel, V., & Gutkind, J. S. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.011 · Cited by 387
Cadherin and catenin alterations in human cancer
Hajra, K. M., & Fearon, E. R. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10083 · Cited by 379
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Yang, W. K., Yan, H., Chen, L., Liu, Q., He, Y., Yu, L., Zhang, S., Huang, D., Tang, L., Kong, X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6691 · Cited by 378
Top-down morphogenesis of colorectal tumors
Shih, I., Wang, T., Traverso, G., Romans, K., Hamilton, S. R., Ben‐Sasson, S. A., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629398 · Cited by 387
Targeting multiple signal transduction pathways through inhibition of Hsp90
Zhang, H., & Burrows, F. J. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0549-9 · Cited by 383
Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus
Berk, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209040 · Cited by 386
Interaction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Mulholland, D. J., Dedhar, S., Coetzee, G. A., & Nelson, C. C. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0034 · Cited by 377
Vallée, A., & Lecarpentier, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00745 · Cited by 380
“org April 2018 | Volume 9 | Article 745 processes, the regulator genes of CTNNB1, AXIN, and APC have been observed to be mutated (179).”
Backgroundβ-catenin interacts with and inhibits NF-κB in human colon and breast cancer
Deng, J., Miller, S. A., Wang, H.-Y., Xia, W., Wen, Y., Zhou, B. P., Li, Y., Lin, S., & Hung, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00154-x · Cited by 370
Widlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 370
Singh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S. (2006) · Endocrinology · doi:10.1210/en.2004-1649 · Cited by 369
Cong, F., Schweizer, L., & Varmus, H. (2004) · Development · doi:10.1242/dev.01318 · Cited by 317
Wang, Y., Lee, A. T. C., Ma, J. Z.-I., Wang, J., Ren, J., Yang, Y., Tantoso, E., Li, K.-B., Ooi, L. L., Tan, P. B. O., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707629200 · Cited by 370
WNT signalling in prostate cancer
Murillo-Garzón, V., & Kypta, R. M. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.144 · Cited by 370
Jaiswal, A. S., Marlow, B. P., Gupta, N., & Narayan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205947 · Cited by 362
Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling
Kielman, M. F., Rindapää, M., Gaspar, C., van Poppel, N., Breukel, C., van Leeuwen, S., Taketo, M. M., Roberts, S., Smits, R., & Fodde, R. (2002) · Nature Genetics · doi:10.1038/ng1045 · Cited by 362
Gavert, N. S., Conacci‐Sorrell, M., Gast, D., Schneider, A., Altevogt, P., Brabletz, T., & Ben‐Ze'ev, A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200408051 · Cited by 359
A review on anti-cancer properties of Quercetin in breast cancer
Ezzati, M., Yousefi, B., Velaei, K., & Safa, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117463 · Cited by 367
beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
Clements, W. M., Wang, J., Sarnaik, A. A., Kim, O. J., MacDonald, J., Fenoglio‐Preiser, C. M., Groden, J. L., & Lowy, A. M. (2002) · PubMed · Cited by 357
Osteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W., Luo, J., Haydon, R. C., & He, T. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 365
Wnts as ligands: processing, secretion and reception
Mikels, A. J., & Nusse, R. (2006) · Oncogene · doi:10.1038/sj.onc.1210053 · Cited by 370
Activation of AXIN2 Expression by β-Catenin-T Cell Factor
Leung, J. Y., Kolligs, F. T., WU, R. T., Zhai, Y., Kuick, R. D., Hanash, S., Cho, K. R., & Fearon, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200139200 · Cited by 355
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344
Pinning down proline-directed phosphorylation signaling
Lu, K. P., Liou, Y.-C., & Zhou, X. Z. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02253-5 · Cited by 351
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
Oshima, T., Abe, M., Asano, J., Hara, T., Kitazoe, K.-I., Sekimoto, E., Tanaka, Y., Shibata, H., Hashimoto, T., Ozaki, S., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4940 · Cited by 343
Linking β-Catenin to Androgen-signaling Pathway
Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111962200 · Cited by 342
Wnt Signaling and Breast Cancer
Howe, L. R., & Brown, A. M. C. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.1.561 · Cited by 342
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation
Li, X., Liu, P., Liu, W., Maye, P. F., Zhang, J., Zhang, Y., Hurley, M. M., Guo, C., Boskey, A. L., Sun, L., et al. (2005) · Nature Genetics · doi:10.1038/ng1614 · Cited by 340
Gonsalves, F. C., Klein, K., Carson, B. B., Katz, S., Ekas, L. A., Evans, S., Nagourney, R., Cardozo, T., Brown, A. M. C., & DasGupta, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017496108 · Cited by 337
Celso, C. L., Prowse, D. M., & Watt, F. M. (2004) · Development · doi:10.1242/dev.01052 · Cited by 339
Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
Park, C. H., Chang, J. Y., Hahm, E., Park, S., Kim, H.-K., & Yang, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.151 · Cited by 337
Stockinger, A., Eger, A., Wolf, J., Beug, H., & Foisner, R. (2001) · Journal of Cell Biology · doi:10.1083/jcb.200104036 · Cited by 380
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Constitutive activation of this pathway is also implicated in cancer development in several other organs (140).”
BackgroundFerrari, G. V. D., Chacón, M. A., Barría, M. I., Garrido, J., Godoy, J. A., Olivares, G. H., Reyes, A. E., Alvarez, A. R., Bronfman, M., & Inestrosa, N. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001208 · Cited by 333
Wissmann, C., Wild, P. J., Kaiser, S., Roepcke, S., Stoehr, R., Woenckhaus, M., Kristiansen, G., Hsieh, J.-C., Hofstaedter, F., Hartmann, A., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1449 · Cited by 333
Martı́nez, A., Castro, A., Dorronsoro, I., & Alonso, M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10011 · Cited by 335
Functional Genomic Analysis of the Wnt-Wingless Signaling Pathway
DasGupta, R., Kaykas, A., Moon, R. T., & Perrimon, N. (2005) · Science · doi:10.1126/science.1109374 · Cited by 333
Identification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325
Kau, T. R., Schroeder, F. C., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 330
Cell Adhesion Molecules: Role and Clinical Significance in Cancer
Makrilia, N., Κόλλιας, Α., Manolopoulos, L., & Syrigos, K. (2009) · Cancer Investigation · doi:10.3109/07357900902769749 · Cited by 330
Ougolkov, A. V., Fernández-Zapico, M. E., Savoy, D. N., Urrutia, R. A., & Billadeau, D. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3642 · Cited by 327
Regulation of NF‐κB by ubiquitination and degradation of the IκBs
Kanarek, N., & Ben‐Neriah, Y. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01098.x · Cited by 327
“Examples of a low affinity substrate are IjBa molecules that are phosphorylated only at a single serine of the b-TrCP degron (Ser36 by IKKe, and Ser32 by Rsk1) (82– 84) or b-catenin tumor mutants at a degron residue (85).”
An ancient role for nuclear β-catenin in the evolution of axial polarity and germ layer segregation
Wikramanayake, A. H., Hong, M., Lee, P. N., Pang, K., Byrum, C. A., Bince, J. M., Xu, R., & Martindale, M. Q. (2003) · Nature · doi:10.1038/nature02113 · Cited by 324
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Bafico, A., Liu, G., Goldin, L., Harris, V., & Aaronson, S. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.032 · Cited by 329
Survivin and molecular pathogenesis of colorectal cancer
Kim, P. J., Plescia, J., Clevers, H. C., Fearon, E. R., & Altieri, D. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13910-4 · Cited by 325
Wnt signaling promotes regeneration in the retina of adult mammals
Osakada, F., Ooto, S., Akagi, T., Mandai, M., Akaike, A., & Takahashi, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4193-06.2007 · Cited by 322
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 323
Gaston‐Massuet, C., Andoniadou, C. L., Signore, M., Jayakody, S. A., Charolidi, N., Kyeyune, R., Vernay, B., Jacques, T. S., Taketo, M. M., Tissier, P. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101553108 · Cited by 321
Wharton, K. A. (2003) · Developmental Biology · doi:10.1006/dbio.2002.0869 · Cited by 315
Aung, T. N., Qu, Z., Kortschak, R. D., & Adelson, D. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030656 · Cited by 331
“For example, CKI downregulates β-catenin through the Wnt signaling pathway, which in turn targets the oncogenes c-MYC and CyclinD1 [84], leading to suppression of MCF-7 cancer stem cell-like side population (SP) cells [85].”
BackgroundEssential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functionsPreprint
Brembeck, F. H., Schwarz, T., Bakkers, J., Wilhelm, S., Hammerschmidt, M., & Birchmeier, W. (2004) · Genes & Development · doi:10.1101/gad.317604 · Cited by 318
Genetics, diagnosis and management of colorectal cancer (Review)
Rosa, M. D., Pace, U., Rega, D., Costabile, V., Duraturo, F., Izzo, P., & Delrio, P. (2015) · Oncology Reports · doi:10.3892/or.2015.4108 · Cited by 326
“tion and proteasomal degradation by its phosphorylation, so preventing its nuclear translocation (17,19).”
BackgroundWD40 Repeat Proteins: Signalling Scaffold with Diverse Functions
Jain, B. P., & Pandey, S. (2018) · The Protein Journal · doi:10.1007/s10930-018-9785-7 · Cited by 315
Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression
Uematsu, K., He, B., You, L., Xu, Z., McCormick, F. P., & Jablons, D. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206817 · Cited by 317
Andrianifahanana, M., Moniaux, N., & Batra, S. K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.01.002 · Cited by 330
Cheon, S. S., Cheah, A. Y. L., Turley, S., Nadesan, P., Poon, R. W. M., Clevers, H. C., & Alman, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102657399 · Cited by 315
Wnt/Beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis
Kolligs, F. T., Bommer, G. T., & Göke, B. (2002) · Digestion · doi:10.1159/000066755 · Cited by 317
The many faces of β-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer
Fuchs, S. Y., Spiegelman, V. S., & Kumar, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207389 · Cited by 317
β-Catenin: A Pivot between Cell Adhesion and Wnt Signalling
Bienz, M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.058 · Cited by 310
Sharma, M., Chuang, W. W., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201919200 · Cited by 311
Craniopharyngiomas of Adamantinomatous Type Harbor β-Catenin Gene Mutations
Sekine, S., Shibata, T., Kokubu, A., Morishita, Y., Noguchi, M., Nakanishi, Y., Sakamoto, M., & Hirohashi, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64477-x · Cited by 308
Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis
Moldes, M., Zuo, Y., Morrison, R. F., Silva, D., Park, B.-H., Liu, J., & Farmer, S. R. (2003) · Biochemical Journal · doi:10.1042/bj20030426 · Cited by 312
Fujimuro, M., Wu, F. Y., Aprhys, C., Kajumbula, H., Young, D. B., Hayward, G. S., & Hayward, S. D. (2003) · Nature Medicine · doi:10.1038/nm829 · Cited by 309
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
Derksen, P. W. B., Tjin, E. P. M., Meijer, H. P., Klok, M. D., MacGillavry, H. D., van Oers, M. H. J., Lokhorst, H. M., Bloem, A. C., Clevers, H. C., Nusse, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305855101 · Cited by 309
Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling
Knöfler, M., & Pollheimer, J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00190 · Cited by 314
“For example endostatin, which could be released from decidual collagen XVIII by EVT-mediated proteolytic cleavage, was shown to impair growth factor-induced AKT/mTOR phosphorylation and cell migration (Pollheimer et al., 2004, 2005, 2011).”
BackgroundHa, N., Tonozuka, T., Stamos, J. L., Choi, H., & Weis, W. I. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.010 · Cited by 304
Müller‐Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Köhler, G., Stelljes, M., Puccetti, E., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2890-2904.2004 · Cited by 308
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, Paul
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-08-01
- Volume
- 14
- Issue
- 15
- Pages
- 1837-1851
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2239090104
- Cited by
- 3,183
- References
- 190
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 25 · 2023: 43 · 2022: 39 · 2021: 46 · 2020: 56 · 2019: 67 · 2018: 71 · 2017: 86 · 2016: 110 · 2015: 144 · 2014: 138 · 2013: 147 · 2012: 174
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Keywords
- Wnt signaling, β-catenin, cancer, oncogenic transformation, transcriptional activation, gene expression profiles, experimental tumor model
- MeSH terms
- Dishevelled Proteins, Animals, Cytoskeletal Proteins, Humans, Neoplasms, Phosphoprotein Phosphatases, Phosphoproteins, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Trans-Activators, Calcium-Calmodulin-Dependent Protein Kinases, Adenomatous Polyposis Coli Protein, Zebrafish Proteins, Glycogen Synthase Kinase 3, Adaptor Proteins, Signal Transducing, Wnt Proteins, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review